BridgeBio Pharma, Inc. (BIT:1BBIO)
Italy · Delayed Price · Currency is EUR 40.61
+4.41 (12.18%)
At close: Aug 12, 2025, 5:30 PM CET
BridgeBio Pharma Market Cap
BridgeBio Pharma has a market cap or net worth of €8.22 billion as of August 14, 2025. Its market cap has increased by 80.99% in one year.
Market Cap
8.22B
Enterprise Value
9.17B
Revenue
200.79M
Ranking
n/a
PE Ratio
n/a
Stock Price
€40.61
Market Cap Chart
Since June 27, 2019, BridgeBio Pharma's market cap has increased from 2.92B to 8.22B, an increase of 181.47%. That is a compound annual growth rate of 18.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 8.22B | 64.12% |
| Dec 31, 2024 | 5.01B | -21.16% |
| Dec 29, 2023 | 6.35B | 496.14% |
| Dec 30, 2022 | 1.07B | -50.63% |
| Dec 31, 2021 | 2.16B | -69.70% |
| Dec 31, 2020 | 7.13B | 84.61% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 27, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UniCredit | 104.91B |
| Intesa Sanpaolo | 94.67B |
| Enel SpA | 79.33B |
| Ferrari | 67.79B |
| Assicurazioni Generali | 50.84B |
| Eni S.p.A. | 44.81B |
| Leonardo S.p.a. | 26.00B |
| Poste Italiane | 25.45B |